Abstract
A CAUSAL ASSOCIATION BETWEEN MEASLES—mumps-rubella (MMR) vaccine and idiopathic thrombocytopenic purpura (ITP) was confirmed using immunisation/hospital admission record linkage. The absolute risk within six weeks of immunisation was 1 in 22 300 doses, with two of every three cases occurring in the six week post-immunisation period being caused by MMR. Children with ITP before MMR had no vaccine associated recurrences.
Full Text
The Full Text of this article is available as a PDF (73.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Begg N. T., Gill O. N., White J. M. COVER (cover of vaccination evaluated rapidly): description of the England and Wales scheme. Public Health. 1989 Mar;103(2):81–89. doi: 10.1016/s0033-3506(89)80021-6. [DOI] [PubMed] [Google Scholar]
- Böttiger M., Christenson B., Romanus V., Taranger J., Strandell A. Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella. Br Med J (Clin Res Ed) 1987 Nov 14;295(6608):1264–1267. doi: 10.1136/bmj.295.6608.1264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohn J. Thrombocytopenia in childhood: an evaluation of 433 patients. Scand J Haematol. 1976 Mar;16(3):226–240. doi: 10.1111/j.1600-0609.1976.tb01142.x. [DOI] [PubMed] [Google Scholar]
- Farrington C. P. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics. 1995 Mar;51(1):228–235. [PubMed] [Google Scholar]
- Farrington P., Pugh S., Colville A., Flower A., Nash J., Morgan-Capner P., Rush M., Miller E. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 1995 Mar 4;345(8949):567–569. doi: 10.1016/s0140-6736(95)90471-9. [DOI] [PubMed] [Google Scholar]
- Neiderud J. Thrombocytopenic purpura after a combined vaccine against morbilli, parotitis and rubella. Acta Paediatr Scand. 1983 Jul;72(4):613–614. doi: 10.1111/j.1651-2227.1983.tb09780.x. [DOI] [PubMed] [Google Scholar]
- Nieminen U., Peltola H., Syrjälä M. T., Mäkipernaa A., Kekomäki R. Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr. 1993 Mar;82(3):267–270. doi: 10.1111/j.1651-2227.1993.tb12657.x. [DOI] [PubMed] [Google Scholar]
- Oski F. A., Naiman J. L. Effect of live measles vaccine on the platelet count. N Engl J Med. 1966 Aug 18;275(7):352–356. doi: 10.1056/NEJM196608182750703. [DOI] [PubMed] [Google Scholar]
- Vlacha V., Forman E. N., Miron D., Peter G. Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination. Pediatrics. 1996 May;97(5):738–739. [PubMed] [Google Scholar]